您的购物车当前为空
P3FI-63 是一种选择性 KDM3B 抑制剂(IC50:7 μM),具有抗肿瘤活性,可用于研究融合阳性横纹肌肉瘤和其他转录成瘾癌症。


为众多的药物研发团队赋能,
让新药发现更简单!
P3FI-63 是一种选择性 KDM3B 抑制剂(IC50:7 μM),具有抗肿瘤活性,可用于研究融合阳性横纹肌肉瘤和其他转录成瘾癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 137 | In Stock | |
| 5 mg | ¥ 289 | In Stock | |
| 10 mg | ¥ 413 | In Stock | |
| 25 mg | ¥ 745 | In Stock | |
| 50 mg | ¥ 1,230 | In Stock | |
| 100 mg | ¥ 1,980 | In Stock |
P3FI-63 相关产品
| 产品描述 | P3FI-63 is a selective KDM3B inhibitor (IC50: 7 μM) with antitumor activity for the study of fusion-positive rhabdomyosarcoma and other transcriptionally addictive cancers. |
| 分子量 | 269.3 |
| 分子式 | C15H15N3O2 |
| CAS No. | 931596-95-1 |
| Smiles | O=C(NNC(=O)C=1C=C(C=C(C1)C)C)C2=NC=CC=C2 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (371.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (18.57 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容